Indo-Bangla Pharmaceuticals Limited announced earnings results for the second quarter ended December 31, 2018. For the second quarter, the company announced sales was BDT 189.405 million compared to BDT 161.100 million a year ago. Operating income was BDT 51.709 million compared to BDT 35.326 million a year ago. Net income was BDT 37.680 million compared to BDT 22.674 million a year ago. Basic earnings per share was BDT 0.37 compared to BDT 0.28 a year ago. For the half year, sales was BDT 355.287 million compared to BDT 320.331 million a year ago. Operating income was BDT 92.988 million compared to BDT 75.414 million a year ago. Net income was BDT 66.870 million compared to BDT 48.713 million a year ago. Basic earnings per share was BDT 0.71 compared to BDT 0.59 a year ago.